Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era

BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing. Development of newer therapeutic modalities has changed the paradigm of HCC treatment in recent years. So, the aim of our study is to analyze the impact of these treatment modalities into the survival of HCC patients, based o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Shah, Chintan, Mramba, Lazarus K., Bishnoi, Rohit, Bejjanki, Harini, Chhatrala, Hardik Satish, Chandana, Sreenivasa R.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674257/
https://ncbi.nlm.nih.gov/pubmed/29184682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars